Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) has a beta value of 1.32 and has seen 8.82 million shares traded in the recent trading session. The company, currently valued at $1.80M, closed the recent trade at $6.93 per share which meant it gained $0.57 on the day or 8.96% during that session. The QNRX stock price is -692.93% off its 52-week high price of $54.95 and 27.71% above the 52-week low of $5.01.
The consensus among analysts is that Quoin Pharmaceuticals Ltd ADR (QNRX) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight.
Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) trade information
Sporting 8.96% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the QNRX stock price touched $6.93 or saw a rise of 27.05%. Year-to-date, Quoin Pharmaceuticals Ltd ADR shares have moved -69.57%, while the 5-day performance has seen it change 12.96%. Over the past 30 days, the shares of Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) have changed 31.25%.
Quoin Pharmaceuticals Ltd ADR (QNRX) estimates and forecasts
The company’s shares have lost -70.45% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -144.01% over the past 5 years.
QNRX Dividends
Quoin Pharmaceuticals Ltd ADR is expected to release its next earnings report in June this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
